REQUEST A DEMO
Total
USD $0.00
Search more companies

Jg Apteki Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Lessors of Real Estate | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Advertising, Public Relations, and Related Services | All Other Miscellaneous Schools and Instruction
Full name: Jg Apteki Sp. z o.o. Profile Updated: May 13, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Jg Apteki Sp. z o.o. is an enterprise in Poland, with the main office in Pogorzela. The company operates in the Department Stores sector. It was established on April 28, 2017. The company’s latest financial report indicates a net sales revenue increase of 12.34% in 2024. A growth of 22.96% was recorded in its total assets. The net profit margin of Jg Apteki Sp. z o.o. increased by 0.68% in 2024.

Headquarters
Ul. Elizy Orzeszkowej 9
Pogorzela; Wielkopolskie; Postal Code: 63-860

Contact Details: Purchase the Jg Apteki Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Jg Apteki Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Jg Apteki Sp. z o.o. report to view the information.
Incorporation Date:
April 28, 2017
Key Executives
Purchase this report to view the information.
President
Company Performance
Financial values in the chart are available after Jg Apteki Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
12.34%
Total operating revenue
12.57%
Operating profit (EBIT)
34.22%
EBITDA
28.07%
Net Profit (Loss) for the Period
21.68%
Total Assets
22.96%
Total Equity
15.9%
Operating Profit Margin (ROS)
1.61%
Net Profit Margin
0.68%
Return on Equity (ROE)
1.83%
Quick Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?